Fig. 6

Occurrence of in-frame and promoter-swapping kinase fusions in different cancer types. A Number of validated and predicted true positive fusion transcripts involving kinases per cancer type. B Number of fusions per kinase family and cancer type for validated and predicted fusion events (see Methods for kinase family abbreviations). C In-frame and promoter-swapping kinases involved in 3 or more validated fusion events per cancer type. D Number of driver fusions predicted by Oncofuse in validated and predicted true positive fusion events. E Percent of fusion events with a high probability (>95%) of being drivers. F Driver probability distribution of predicted and validated kinase fusions